163 related articles for article (PubMed ID: 35793641)
1. Nodal Assessment in Endometrial Atypical Hyperplasia.
Capozzi VA; Sozzi G; Butera D; Chiantera V; Ghi T; Berretta R
Gynecol Obstet Invest; 2022; 87(3-4):226-231. PubMed ID: 35793641
[TBL] [Abstract][Full Text] [Related]
2. The utility of sentinel lymph node mapping in the management of endometrial atypical hyperplasia.
Touhami O; Grégoire J; Renaud MC; Sebastianelli A; Grondin K; Plante M
Gynecol Oncol; 2018 Mar; 148(3):485-490. PubMed ID: 29290489
[TBL] [Abstract][Full Text] [Related]
3. Preoperative predictors of endometrial cancer at time of hysterectomy for endometrial intraepithelial neoplasia or complex atypical hyperplasia.
Vetter MH; Smith B; Benedict J; Hade EM; Bixel K; Copeland LJ; Cohn DE; Fowler JM; O'Malley D; Salani R; Backes FJ
Am J Obstet Gynecol; 2020 Jan; 222(1):60.e1-60.e7. PubMed ID: 31401259
[TBL] [Abstract][Full Text] [Related]
4. Lymph node assessment at the time of hysterectomy has limited clinical utility for patients with pre-cancerous endometrial lesions.
Sullivan MW; Philp L; Kanbergs AN; Safdar N; Oliva E; Bregar A; Del Carmen MG; Eisenhauer EL; Goodman A; Muto M; Sisodia RC; Growdon WB
Gynecol Oncol; 2021 Sep; 162(3):613-618. PubMed ID: 34247769
[TBL] [Abstract][Full Text] [Related]
5. A prospective investigation of fluorescence imaging to detect sentinel lymph nodes at robotic-assisted endometrial cancer staging.
Paley PJ; Veljovich DS; Press JZ; Isacson C; Pizer E; Shah C
Am J Obstet Gynecol; 2016 Jul; 215(1):117.e1-7. PubMed ID: 26743505
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer and hyperplasia rate in women before menopause with abnormal uterine bleeding undergoing endometrial sampling.
Gawron I; Łoboda M; Babczyk D; Ludwin I; Basta P; Pityński K; Ludwin A
Przegl Lek; 2017; 74(4):139-43.. PubMed ID: 29696944
[TBL] [Abstract][Full Text] [Related]
7. Call for Surgical Nodal Staging in Women with ESMO/ESGO/ESTRO High-Intermediate Risk Endometrial Cancer: A Multicentre Cohort Analysis from the FRANCOGYN Study Group.
Ouldamer L; Bendifallah S; Body G; Canlorbe G; Touboul C; Graesslin O; Raimond E; Collinet P; Coutant C; Lavoué V; Lévêque J; Daraï E; Ballester M;
Ann Surg Oncol; 2017 Jun; 24(6):1660-1666. PubMed ID: 28058558
[TBL] [Abstract][Full Text] [Related]
8. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging.
Cusimano MC; Vicus D; Pulman K; Maganti M; Bernardini MQ; Bouchard-Fortier G; Laframboise S; May T; Hogen LF; Covens AL; Gien LT; Kupets R; Rouzbahman M; Clarke BA; Mirkovic J; Cesari M; Turashvili G; Zia A; Ene GEV; Ferguson SE
JAMA Surg; 2021 Feb; 156(2):157-164. PubMed ID: 33175109
[TBL] [Abstract][Full Text] [Related]
9. Hysteroscopic biopsy compared with endometrial curettage to assess the preoperative rate of atypical hyperplasia underestimating endometrial carcinoma.
Garuti G; Sagrada PF; Frigoli A; Fornaciari O; Finco A; Mirra M; Soligo M
Arch Gynecol Obstet; 2023 Sep; 308(3):971-979. PubMed ID: 37160470
[TBL] [Abstract][Full Text] [Related]
10. [Surgical treatment of precancer and cancer of endometrium].
Ivanov S; Khadzhiolov N; Batashki I
Akush Ginekol (Sofiia); 2007; 46(6):12-4. PubMed ID: 17974165
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of preoperative endometrial biopsy and intraoperative frozen section in predicting the final pathological diagnosis of endometrial cancer.
Mandato VD; Torricelli F; Mastrofilippo V; Palicelli A; Ciarlini G; Pirillo D; Annunziata G; Aguzzoli L
Surg Oncol; 2020 Dec; 35():229-235. PubMed ID: 32932219
[TBL] [Abstract][Full Text] [Related]
12. The impact of the type of nodal assessment on prognosis in patients with high-intermediate and high-risk ESMO/ESGO/ESTRO group endometrial cancer. A multicenter Italian study.
Buda A; Restaino S; Di Martino G; De Ponti E; Monterossi G; Dinoi G; Magni S; Quagliozzi L; Dell'Orto F; Ciccarone F; Lamanna M; Scambia G; Landoni F; Fanfani F
Eur J Surg Oncol; 2018 Oct; 44(10):1562-1567. PubMed ID: 30077521
[TBL] [Abstract][Full Text] [Related]
13. Concordance between preoperative ESMO-ESGO-ESTRO risk classification and final histology in early-stage endometrial cancer.
Daix M; Angeles MA; Migliorelli F; Kakkos A; Martinez Gomez C; Delbecque K; Mery E; Tock S; Gabiache E; Decuypere M; Goffin F; Martinez A; Ferron G; Kridelka F
J Gynecol Oncol; 2021 Jul; 32(4):e48. PubMed ID: 33908709
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy at robotic-assisted hysterectomy for atypical hyperplasia and endometrial cancer.
El-Achi V; Burling M; Al-Aker M
J Robot Surg; 2022 Oct; 16(5):1111-1115. PubMed ID: 34855134
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node mapping with pathologic ultrastaging: a valuable tool for assessing nodal metastasis in low-grade endometrial cancer with superficial myoinvasion.
Kim CH; Khoury-Collado F; Barber EL; Soslow RA; Makker V; Leitao MM; Sonoda Y; Alektiar KM; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2013 Dec; 131(3):714-9. PubMed ID: 24099838
[TBL] [Abstract][Full Text] [Related]
16. The Reliability of Intraoperative Assessment on Predicting Tumor Size, Myometrial Invasion, and Cervical Involvement in Patients With a Preoperative Diagnosis of Complex Atypical Hyperplasia or (Clinical Stage I) Endometrial Cancer: A Prospective Cohort Study.
Smith BQ; Boone JD; Thomas ED; Turner TB; McGwin G; Stisher AM; Leath CA; Novak L; Huh WK
Am J Clin Oncol; 2020 Feb; 43(2):122-127. PubMed ID: 31764025
[TBL] [Abstract][Full Text] [Related]
17. The ability of endometrial biopsies with atypical complex hyperplasia to guide surgical management.
Miller C; Bidus MA; Pulcini JP; Maxwell GL; Cosin JA; Rose GS
Am J Obstet Gynecol; 2008 Jul; 199(1):69.e1-4. PubMed ID: 18241812
[TBL] [Abstract][Full Text] [Related]
18. Clinically significant endometrial cancer risk following a diagnosis of complex atypical hyperplasia.
Costales AB; Schmeler KM; Broaddus R; Soliman PT; Westin SN; Ramirez PT; Frumovitz M
Gynecol Oncol; 2014 Dec; 135(3):451-4. PubMed ID: 25316176
[TBL] [Abstract][Full Text] [Related]
19. Relevance of sentinel lymph node procedure for patients with high-risk endometrial cancer.
Naoura I; Canlorbe G; Bendifallah S; Ballester M; Daraï E
Gynecol Oncol; 2015 Jan; 136(1):60-4. PubMed ID: 25449312
[TBL] [Abstract][Full Text] [Related]
20. Sentinel Lymph Node Mapping in Endometrial Cancer: An Update.
Khoury-Collado F; St Clair C; Abu-Rustum NR
Oncologist; 2016 Apr; 21(4):461-6. PubMed ID: 26961924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
